gnbt .. I'm a long time holder. Yes the company has been inept with the oral insulin. But this month their sub releases interim p 2 results on the md Anderson led bc trial. Early results were excellent so strong reason to believe they will be at least a double if not a home run, enough for a deal. The experts say this is better than galena's product so do the math on market cap difference. Huge.
Whether this is a trade or you care about the story good luck
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.